[Study of the ocular findings in Stevens-Johnson syndrome patients from a tertiary ophthalmologic center]

Arq Bras Oftalmol. 2009 May-Jun;72(3):370-4. doi: 10.1590/s0004-27492009000300017.
[Article in Portuguese]

Abstract

Purpose: To evaluate the epidemiology, possible etiologic factors, complications and treatment of a group of patients with ocular complications secondary to Stevens-Johnson syndrome.

Methods: Twenty-two consecutive patients with Stevens-Johnson syndrome were studied. The patients were examined according to the following protocol: identification, previous clinical history, systemic and ophthalmologic manifestations and possible etiologic factors.

Results: A total of 22 patients with Stevens-Johnson syndrome were identified. Fifteen patients (68%) were female, 7 (32%) male. Ten patients were caucasian (45.4%), 9 brownish (22%), 2 black (9%) and 1 yellow (4.5%). Mean age was 27.1 (8 to 62). Medications were the most commonly identified etiologic factor (90.9%), followed by skin herpetic infection (4.5%) and idiopathic (4.5%). Dipirone (36.3%) was the most frequently identified agent, followed by seizure medications (22.7%), non-steroidal anti-inflammatory drugs (13.6%), sulfonamides (9.0%), penicillin (4.5%), spironolactone (4.5%) and dihydroprogestagen and stradiol (4.5%). Twenty-one patients (95.4%) had ophthalmologic complications and sixteen patients (72.7%) underwent ophthalmologic surgical procedures.

Conclusions: The results of this study show important epidemiological aspects of Stevens-Johnson syndrome in our environment, specially related to age, etiology and ocular complications.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anticonvulsants / adverse effects
  • Child
  • Dipyrone / adverse effects
  • Eye Diseases / etiology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Stevens-Johnson Syndrome / complications*
  • Young Adult

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Anticonvulsants
  • Dipyrone